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ABSTRACT 
Background and Objectives: During the index procedure of catheter ablation (CA) for atrial fibrillation (AF), it 
is important to assess whether other atrial or ventricular tachyarrhythmia coexist. Their symptoms are often 
attributed to residual tachycardia after successful elimination of AF by CA. This tachycardia could also be non-pul-
monary vein (PV) foci initiated AF. This study examined the coexistence of other sustained tachyarrhythmia of 
patients who underwent radiofrequency CA (RFCA) for AF. Subjects and Methods: Four hundred fifty-nine con-
secutive patients (375 males, aged 53.4±11.4 years) who underwent RFCA for AF were investigated. Atrial and ven-
tricular programmed stimulation (PS) with or without isoproterenol infusion were performed, and spontaneously 
developed tachycardias were analyzed. Results: Fifteen patients (3.3% of total) were diagnosed to have other sus-
tained arrhythmias that included slow-fast type atrioventricular nodal reentrant tachycardia (AVNRT, n=6), atrio-
ventricular reentrant tachycardia (AVRT, n=5) that utilized left posteroseptal (n=4) and parahisian bypass tract 
(n=1), atrial tachycardia (AT, n=2) originating from the foramen ovale (n=1) and the ostium of coronary sinus 
(n=1), sustained ventricular tachycardia (VT, n=2) involving one from the apical posterolateral wall of left ventri-
cule in a normal heart and one from an anterolateral wall in an underlying myocardial infarction (MI). These sus-
tained tachycardias were neither clinically documented nor had structural heart diseases, with the exception of 
one patient with MI associated VT. Two patients had the triple tachycardia; one involved AVNRT, AVRT, and AF, 
and the other involved VT, AT, and AF. All associated tachycardias were successfully eliminated by RFCA. Con-
clusion: Fifteen (3.3%) patients with AF had coexisting sustained tachycardia. RFCA was successful in these 
patients. Identification of tachycardia by PS before RFCA for AF should be done to maximize the efficacy of the 
first ablation session. (Korean Circ J 2010;40:235-238) 
 





Patients with supraventricular tachycardia (SVT) oc-
casionally experience atrial fibrillation (AF).
1-3) Some 
forms of AF could be caused by a rapid atrial tachycar-
dia (AT) and radiofrequency catheter ablation (RFCA) 
of this focus is curative.
3)4) AF can be associated with 
other forms of SVT.
5)6) AF may initiate from atrial flut-
ter,
4) atrioventricular nodal reentrant tachycardia (AV-
NRT),
7) or atrioventricular reentrant tachycardia (AVRT) 
due to an accessory pathway.
8) Sometimes, palpitation 
or other symptoms in patients with AF may be attribut-
able to these tachyarrhymias.   
Therefore, these coexistent arrhythmias could cause 
residual symptoms after catheter ablation (CA) for AF. 
Identification of patients with coexistent tachyarrhyth-
mia-induced AF could affect the ablation strategy and 
improve the efficacy of the CA procedure. The aim of 
this study was to investigate the prevalence of coexistence 
of other sustained tachyarrhythmia of patients who un-
derwent RFCA for AF and the effect of their ablation on 
the procedural outcome. 
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Subjects and Methods 
 
Patient records 
We retrospectively collected patient data from medi-
cal records. Medical records in our institution were se-
arched from 1998-2007 and all patients who were re-
ferred for CA of AF were included in this study. Elec-
trophysiology study and ablation reports, as well as com-
plete medical records of patients with symptomatic, pa-
roxysmal AF (PAF) that was defined as AF with self-ter-
mination within 7 days or persistent AF that was defin-
ed without spontaneous termination in 7 days and which 
required chemical or electrical cardioversion were review-
ed. Holter recordings, events recordings, and resting elec-
trocardiograms were reviewed. All patients were subject-
ed to a full diagnostic electrophysiological assessment 
with rapid atrial pacing with isoproterenol as described 
below to reveal arrhythmogenic foci. Only patients re-
ferred for an initial AF ablation were included. The study 
was approved by our Institutional Review Boards and all 
patients had provided their written informed consent. 
 
Electrophysiological study and radiofrequency ca-
theter ablation 
Electrophysiological studies were carried out accord-
ing to standard protocol in patients sedated with mida-
zolam and phentanyl sodium. Each patient was in the 
post-absorptive state of the antiarrhyhmic agent and the 
antiarrhythmic agent had been discontinued for the 
number of days corresponding to at least 4-5 times the 
agent’s half-life. A duodecapolar catheter was positioned 
in the coronary sinus and the lateral wall of the right 
atrium (RA), a decapolar catheter in the RA, and a qua-
dripolar catheter in the superior vena cava (SVC). Pacing 
with RA and right ventricular refractory periods at one 
or more cycle lengths were performed as well as decre-
mental pacing. Arrhythmia induction was facilitated by 
isoproterenol infusion at rates up to 10 mg/min. Bipolar 
electrograms were filtered at 30-500 Hz and displayed and 
acquired, together with surface electrocardiograms. 
Ablation of accessory pathways and slow pathway for 
AVNRT was performed according to standard techni-
ques. RFCA for AF was accomplished via an ostial or 
circumferential approach, and induction of sustained su-
praventricular arrhythmias other than AF was perform-
ed after completion of RFCA for AF. 
 
Follow up 
Patients were followed-up by clinical assessments and 
ambulatory electrocardiographic monitoring. Initial post-
ablation follow-up took place at 1 week and 1 month, 
and every 3-6 months thereafter. Beyond this interval, 
6-month outpatient clinic visits with Holter monitor-
ing were scheduled. All patients were instructed to main-
tain personal records with descriptions of every episode 
of symptomatic palpitations. A successful outcome over 
the follow-up period was defined as the lack of electro-





In total, 459 patients (374 males, aged 53.4±11.4 
years) were included in the study. Analysis of medical 
records, ablation reports, and electrophysiology reveal-
ed 15 (3.3%, aged 45.4±14.1 years) patients had accom-
panying sustained arrhythmias, which comprised AV-
NRT (n=6), AVRT (n=5), AT (n=2), and ventricular 
tachycardia (VT) (n=2). All patients with AVNRT were 
slow-fast type; cases were revealed by programmed sti-
mulation (PS) (n=4) and during catheter manipulat-
ion (n=1) before RFCA for AF, and one AVNRT was 
clinically documented 2 months after AF ablation. All 
five patients with AVRT were identified to have a con-
cealed accessory pathway, utilizing the left posteroseptal 
(n=4) and parahisian bypass tracts (n=1). Two ATs ori-
ginated from the foramen ovale (n= 1) and the ostium 
of CS (n=1), which were not related to initiation and 
maintenance of AF; these were documented by PS be-
fore RFCA for AF. Patients with the other tachyarrhyth-
mias were younger (45.4±14.1 years) than those with-
out them (53.4±11.4 years, p=0.01). Sustained VTs 
were identified in two patients, one from the apical post-
erolateral wall of left ventricule in a normal heart and 
one from anterolateral wall in an underlying myocar-
dial infarction (MI). Fourteen of the 15 patients with ta-
chycardia were not clinically documented. None had a 
structural heart disease, except one patient with VT in 
MI. Two patients had triple tachycardia; one involved 
AVNRT, AVRT, and AF, and the other involved AF, AT, 
and idiopathic VT. All associated tachycardias were suc-
cessfully eliminated by RFCA. All 13 patients with SVT 
were free from AF during follow-up (27.9±19.6 months) 
without use of an anti-arrhythmic agent except one pa-
tient. One other patient with persistent AF underwent 




In this study, we report a 3.3% incidence of other sus-
tained tachyarrhythmias in patients who presented ex-
clusively with drug refractory AF at the time of CA. Al-
though this represents a small proportion of the total 
population of patients who present with AF, it is not in-
significant. It has been recently described that some 
forms of AF might be due to the presence of a rapid AT 
and that radiofrequency ablation of the foci of AT re-
sulted in cure of the AF.
4) It is also well-known that pa-
tients with an atrioventricular (AV) accessory pathway 
have a higher incidence of AF than the general populat- 
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ion, and that ablation of the accessory pathway is asso-
ciated with a decrease in the subsequent incidence of 
AF.
9) 
Previous reports have described AVNRT-initiated 
AF.
7)10)11) AVNRT as an isolated trigger of AF was first 
described by Brugada et al.
10) Sauer et al.
7) reported a 
4.3% incidence of inducible AVNRT among patients 
referred for AF ablation. In their patients, slow path-
way ablation abolished AF recurrences. It seems that in 
a considerable proportion of such patients, particularly 
in the young, elimination of AVNRT results in abolition 
of the AF episodes as well. Delise et al.
12) reported an 
AF cure rate of 70% of patients presenting with both 
AVNRT and AF with slow-pathway modification alone. 
In addition, AF triggered by pulmonary vein (PV) ec-
topy during AVNRT has also been described and likely 
explains why some patients with AVNRT present with 
recurrent AF after successful slow-pathway modificat-
ion.
6) In contrast to earlier studies, we did not find any 
patient with AVNRT presenting as non-PV foci initiated 
AF. In one study, underlying arrhythmia was revealed in 
7.6% of patients referred for AF ablation using electro-
physiology, with study ablation proving successful results 
in abolishing PAF. Atrial flutter appeared to be the most 
common arrhythmia in this respect, followed by AVN-
RT, AVRT, and AT.
13) Approximately 30% of patients 
undergoing successful ablation of atrial flutter may de-
velop AF at follow-up,
14) whereas a similar proportion of 
patients subjected to PV ablation for AF may experience 
isthmusdependent atrial flutter following the proce-
dure.
15) Typical atrial flutter and AF appear to represent 
separate clinical entities, with recent electrophysiologic 
data indicating important interrelationships between 
these arrhythmias and PAF in 12-46% of patients with 
unifocal or multifocal ectopic ATs.
16) But, we did not in-
clude atrial flutter following PV isolation for AF, and 
atrial flutter did not develop while taking antiarrhyth-
mic agents for AF. It may be that atrial flutter is not in-
dependent of AF, but rather lies at the same root. Fur-
thermore, a detailed electrophysiology study may reveal 
the interactive mechanism of AF and other SVT or VT. 
However, we were unable to detect any SVT or VT spon-
taneously converting to AF, or visa versa.   
AVRT can convert to AF and ablation of an accessory 
pathway may abolish AF recurrences, particularly in the 
young. In the series of Dagres et al.,
17) 12% of patients 
with AF in the context of an accessory pathway and <50-
years-of-age experienced AF recurrence following abl-
ation of the pathway, as opposed to 55% of those >60-
years-of-age. Ablation therapy of the underlying arrhy-
thmia may not necessarily eliminate future AF recurr-
ences.
8)18)  
Radiofrequency ablation either applied focally or cir-
cumferentially to isolate the PVs from the LA has been 
demonstrated to cure AF in a subgroup of patients.
19)20) 
In one study, enlargement of the LA and septal origin 
of the atrial focus were independent predictors of co-
existing AF and patients with a septal origin of the focal 
AT were older and had a higher rate of structural heart 
disease than patients with a non-septal foci.
21) In the pre-
sent study, AT originating from the foramen ovale did 
not initiate AF. Two patients underwent the CA for SVT 
after RFCA for AF. Their symptoms were attributed to 
residual tachycardias after successful elimination of AF 
by CA. One of these patients had AVRT with left pos-
teroseptal bypass tract and the other had a slow-fast type 
AVNRT. In two patients with AF, sustained VT occurr-
ed. One VT developed in a patient who had previously 
experienced a MI. These VTs might have been missed 
if we did not perform PS including ventricular pacing. 
Although this finding is from just one patient, it is note-
worthy in suggesting ventricular PS before CA has sig-
nificant diagnostic value in patients with AF, especially 
in patients with structural heart diseases.   
The success rate for curing AF along with slow-path-
way modification is superior only to those with target-
ed AF ablation without inducible AVNRT.
7) In our study, 
even we did not find the AVNRT initiated AF, success-
ful elimination of AVNRT may have contributed to the 
elimination of potential triggers of AF.   
 
Study limitations 
The present study had three unavoidable limitations. 
It was retrospective. Secondly, patients with associated 
tachyarrhythmia did not have evidence of a transition 
from tachycardia to AF. Thirdly, the electrophysiological 
study did not follow the same protocol in all patients.   
 
Conclusion 
In our study, 3.3% of patients with AF had coexisting 
sustained tachycardia, for which CA was performed. Id-
entification of these tachycardias by PS prior to CA for 
AF should be done to increase the efficacy of the first 
ablation session. Patient symptoms were mainly attribut-
ed to residual tachycardia after successful elimination 
of AF by RFCA.   
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